North Dakota State Investment Board Acquires New Holdings in Humana Inc. $HUM

North Dakota State Investment Board acquired a new stake in Humana Inc. (NYSE:HUM) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 5,922 shares of the insurance provider’s stock, valued at approximately $1,517,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Montag A & Associates Inc. lifted its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the last quarter. CoreCap Advisors LLC increased its position in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the period. Rosenberg Matthew Hamilton increased its position in Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Larson Financial Group LLC increased its position in Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares during the period. Finally, Fulcrum Asset Management LLP acquired a new position in Humana in the 3rd quarter valued at approximately $42,000. Institutional investors own 92.38% of the company’s stock.

Humana Trading Up 1.3%

NYSE:HUM opened at $309.85 on Wednesday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $37.20 billion, a price-to-earnings ratio of 33.14, a PEG ratio of 2.84 and a beta of 0.68. The firm has a fifty day simple moving average of $210.28 and a two-hundred day simple moving average of $226.76. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $315.35.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period last year, the company posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts expect that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 37.86%.

Analysts Set New Price Targets

HUM has been the subject of several recent research reports. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research report on Tuesday, April 21st. Cantor Fitzgerald upped their price target on shares of Humana from $201.00 to $264.00 in a research report on Thursday, April 30th. Jefferies Financial Group upped their price target on shares of Humana from $235.00 to $290.00 in a research report on Thursday, April 30th. The Goldman Sachs Group upped their price target on shares of Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research report on Thursday, April 30th. Finally, Morgan Stanley upped their price target on shares of Humana from $146.00 to $217.00 and gave the company an “underweight” rating in a research report on Friday. Seven research analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $249.91.

Insider Activity

In other Humana news, insider Sanjay K. Shetty acquired 810 shares of Humana stock in a transaction dated Monday, February 23rd. The stock was purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.20% of the stock is owned by corporate insiders.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.